Annexon, Inc. (ANNX) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-14

Key Insights

The filing reports that William H. Carson, a director of Annexon, Inc., acquired 8,000 shares of the company's common stock on April 10, 2026 at a price of $6.2 per share.
The acquisition was made pursuant to Carson's Rule 10b5-1 trading plan, which suggests a level of confidence in the company's long-term prospects.
With the additional 8,000 shares, Carson now beneficially owns a total of 70,405 shares of Annexon, Inc., indicating a significant personal investment in the company.

Want the newest filings?

This analysis covers the filing from 2026-04-14. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-12

William H. Carson, a director of Annexon, Inc., purchased 8,000 shares of the company's common stock at $5.67 per share on March 10, 2026.
This insider buying transaction was made pursuant to a pre-existing Rule 10b5-1 trading plan, indicating a level of confidence in the company's prospects.
With this purchase, Carson's total beneficial ownership in Annexon increased to 62,405 shares, suggesting his alignment with shareholder interests.

Filed: 2026-02-20

The reporting person, Dean Richard Artis, who is the EVP and Chief Scientific Officer of Annexon, Inc., sold 5,290 shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
The sale was executed at a weighted average price of $5.1 per share, with the shares being sold in multiple trades ranging from $4.925 to $5.155 per share.
Following the transaction, the reporting person continues to beneficially own 123,487 shares of Annexon's common stock.

Filed: 2026-02-20

The reporting person, Jennifer Lew, who is the EVP & Chief Financial Officer of Annexon, Inc. (ANNX), sold 7,851 shares of common stock on 02/18/2026 at an average price of $5.11 to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
The sale of shares by the CFO may indicate a short-term liquidity need, but the transaction appears to be routine and does not necessarily signal a broader negative outlook on the company's prospects.
The reporting person continues to hold 113,765 shares of Annexon, Inc. common stock, suggesting she maintains a significant ownership stake in the company.

Filed: 2026-02-20

The reporting person, Jamie Dananberg, who is the Chief Medical Officer of Annexon, Inc., sold 5,290 shares of the company's common stock on February 18, 2026 to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
The sale price ranged from $4.93 to $5.16 per share, with a weighted average sale price of $5.10 per share.
Following the reported transaction, the reporting person beneficially owns 73,152 shares of Annexon's common stock.

Filed: 2026-02-20

The reporting person, Michael Overdorf, who is the EVP & Chief Business Officer of Annexon, Inc. (ANNX), sold 6,225 shares of common stock on 2/18/2026 to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs).
The sale was executed in multiple trades at a weighted average price of $5.10, with the prices ranging from $4.93 to $5.16.
Following the reported transaction, the reporting person now beneficially owns 124,464 shares of Annexon's common stock.

Filed: 2026-02-20

The reporting person, Ted Yednock, sold 7,857 shares of Annexon, Inc. (ANNX) common stock on February 18, 2026 to cover tax withholding obligations related to the vesting of restricted stock units.
The sale price ranged from $4.925 to $5.17 per share, with a weighted average sale price of $5.11 per share.
Following the reported transaction, the reporting person continues to beneficially own 97,227 shares of Annexon, Inc. common stock.

Filed: 2026-01-02

The reporting person, William H. Carson, is a director of Annexon, Inc. and has purchased 4,115 shares of the company's common stock at $5.02 per share.
The insider transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2025, indicating a pre-planned nature of the purchase.
The reporting person now holds a total of 54,405 shares of Annexon's common stock, representing a direct ownership position.

Other reports for Annexon, Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.